Abstract
There are several classification problems, which are difficult to solve using a single classifier because of the complexity of the decision boundary. Whereas a wide variety of multiple classifier systems have been built with the purpose of improving the recognition process, there is no universal method performing the best. This paper provides a review of different multi-classifiers and some application of them. Also it is shown a novel model of combining classifiers and its application to predicting human immunodeficiency virus drug resistance from genotype. The proposal is based on the use of different classifier models. It clusters the dataset considering the performance of the base classifiers. The system learns how to decide from the groups, by using a meta-classifier, which are the best classifiers for a given pattern. The proposed model is compared with well-known classifier ensembles and individual classifiers as well resulting the novel model in similar or even better performance.
Keywords: Classification, Ensemble classifiers, HIV prediction, Machine learning, Multi-classifiers.
Current Topics in Medicinal Chemistry
Title:Multi-Classifier Based on Hard Instances- New Method for Prediction of Human Immunodeficiency Virus Drug Resistance
Volume: 13 Issue: 5
Author(s): Isis Bonet, Joel Arencibia, Mario Pupo, Abdel Rodriguez, Maria M. Garcia and Ricardo Grau
Affiliation:
Keywords: Classification, Ensemble classifiers, HIV prediction, Machine learning, Multi-classifiers.
Abstract: There are several classification problems, which are difficult to solve using a single classifier because of the complexity of the decision boundary. Whereas a wide variety of multiple classifier systems have been built with the purpose of improving the recognition process, there is no universal method performing the best. This paper provides a review of different multi-classifiers and some application of them. Also it is shown a novel model of combining classifiers and its application to predicting human immunodeficiency virus drug resistance from genotype. The proposal is based on the use of different classifier models. It clusters the dataset considering the performance of the base classifiers. The system learns how to decide from the groups, by using a meta-classifier, which are the best classifiers for a given pattern. The proposed model is compared with well-known classifier ensembles and individual classifiers as well resulting the novel model in similar or even better performance.
Export Options
About this article
Cite this article as:
Bonet Isis, Arencibia Joel, Pupo Mario, Rodriguez Abdel, Garcia Maria M. and Grau Ricardo, Multi-Classifier Based on Hard Instances- New Method for Prediction of Human Immunodeficiency Virus Drug Resistance, Current Topics in Medicinal Chemistry 2013; 13 (5) . https://dx.doi.org/10.2174/1568026611313050011
DOI https://dx.doi.org/10.2174/1568026611313050011 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Neurotrophins and Their Role in Alzheimers Disease
Current Neuropharmacology The Infectious Etiology of Alzheimer’s Disease
Current Neuropharmacology Anticancer Potential of Thiazole Derivatives: A Retrospective Review
Mini-Reviews in Medicinal Chemistry Polyphenols: Well Beyond The Antioxidant Capacity: Gallic Acid and Related Compounds as Neuroprotective Agents: You are What You Eat!
Current Pharmaceutical Biotechnology Immunomodulatory Properties of Antibiotics
Current Molecular Pharmacology Epilepsy, Regulation of Brain Energy Metabolism and Neurotransmission
Current Medicinal Chemistry Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Current Neuropharmacology Telomere Shortening Is a Sole Mechanism of Aging in Mammals
Current Aging Science Valproic Acid As Anti-Cancer Drug
Current Pharmaceutical Design Nonnucleoside Inhibitors of Adenosine Kinase
Current Pharmaceutical Design Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
Current Pharmaceutical Biotechnology Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Current Organic Chemistry Non-Analgesic Effects of Opioids: Neuroprotection in the Retina
Current Pharmaceutical Design Nutrient Regulation of Tumor and Vascular Endothelial Cell Proliferation
Current Cancer Drug Targets Clinical Considerations of Focal Drug Delivery in Cancer Treatment
Current Drug Delivery Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction
CNS & Neurological Disorders - Drug Targets The Therapeutical Potential of a Novel Pterocarpanquinone LQB-118 to Target Inhibitor of Apoptosis Proteins in Acute Myeloid Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Ethanol Metabolism and Effects: Nitric Oxide and its Interaction
Current Clinical Pharmacology Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery
Endocrine, Metabolic & Immune Disorders - Drug Targets